INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 63 filers reported holding INSTIL BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,606,000 | -6.0% | 331,872 | -10.3% | 0.20% | -37.1% |
| Q2 2022 | $1,708,000 | -57.9% | 369,800 | -1.9% | 0.31% | -40.5% |
| Q1 2022 | $4,054,000 | -82.2% | 377,091 | -70.5% | 0.53% | -68.0% |
| Q3 2021 | $22,828,000 | -30.4% | 1,277,091 | -24.7% | 1.65% | -40.3% |
| Q2 2021 | $32,783,000 | -29.2% | 1,696,850 | -8.1% | 2.76% | -39.0% |
| Q1 2021 | $46,319,000 | – | 1,846,850 | – | 4.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $16,255,471 | 100.00% |
| CPMG Inc | 8,218,467 | $3,517,504 | 1.92% |
| Western Standard LLC | 1,796,987 | $769,110 | 0.70% |
| Vivo Capital, LLC | 12,486,787 | $5,344,345 | 0.59% |
| Nantahala Capital Management | 1,000,000 | $428,000 | 0.04% |
| Baker Brothers Advisors | 4,704,395 | $2,013,481 | 0.01% |
| HCR Wealth Advisors | 40,000 | $17,120 | 0.00% |
| Hennion & Walsh Asset Management, Inc. | 98,080 | $41,978 | 0.00% |
| Long Focus Capital Management, LLC | 100,000 | $42,800 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 867,279 | $371,195 | 0.00% |